Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China flag China · Delayed Price · Currency is CNY
10.33
-0.19 (-1.81%)
May 20, 2026, 2:35 PM CST

SHA:603998 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,7341,6891,7101,5691,7511,535
Other Revenue
57.4257.4267.6959.0941.2732.12
1,7911,7461,7771,6291,7921,567
Revenue Growth (YoY)
1.93%-1.75%9.15%-9.12%14.36%22.54%
Cost of Revenue
487.45496.61517.01522.25589.28566.27
Gross Profit
1,3041,2501,2601,1061,2031,001
Selling, General & Admin
782.33754.97846.57804.8940.45798.94
Research & Development
158.77154.47139.21107.9370.451.4
Other Operating Expenses
33.2631.3423.329.2728.5524.33
Operating Expenses
981.81945.231,013942.991,049877.34
Operating Income
321.87304.61247.14163.31153.98123.37
Interest Expense
-12.67-14.8-21.79-20.81-22.95-18.39
Interest & Investment Income
5.415.6748.2210.641711.77
Currency Exchange Gain (Loss)
-0.08-0.08--0.16-0.57
Other Non Operating Income (Expenses)
4.614.52-1.25-2.22-15.14-2.46
EBT Excluding Unusual Items
319.14299.92272.32150.92287.05103.72
Impairment of Goodwill
-3.82-3.82-5.38---
Gain (Loss) on Sale of Investments
0.02-0.8-0.82-5.46-0.06-21.17
Gain (Loss) on Sale of Assets
36.151.390.7511.38-1.03-0.94
Asset Writedown
-0.86-0.64-0.05---
Other Unusual Items
7.147.1819.1746.540.639.18
Pretax Income
357.71353.24285.99203.34326.5790.79
Income Tax Expense
55.9450.6136.1423.7149.8720.87
Earnings From Continuing Operations
301.77302.64249.85179.62276.7169.92
Minority Interest in Earnings
4.753.755.377.29.150.12
Net Income
306.52306.39255.22186.82285.8570.04
Net Income to Common
306.52306.39255.22186.82285.8570.04
Net Income Growth
12.16%20.05%36.61%-34.64%308.13%9.79%
Shares Outstanding (Basic)
438438433434433438
Shares Outstanding (Diluted)
438438440445433438
Shares Change (YoY)
-0.64%-0.53%-1.08%2.70%-1.06%2.93%
EPS (Basic)
0.700.700.590.430.660.16
EPS (Diluted)
0.700.700.580.420.660.16
EPS Growth
12.88%20.69%38.09%-36.36%312.50%6.67%
Free Cash Flow
335.74282.12100.16-131.24130.380.92
Free Cash Flow Per Share
0.770.650.23-0.290.300.00
Dividend Per Share
0.3000.3000.2500.2900.3500.150
Dividend Growth
20.00%20.00%-13.79%-17.14%133.33%25.00%
Gross Margin
72.78%71.56%70.91%67.93%67.12%63.86%
Operating Margin
17.97%17.44%13.90%10.03%8.59%7.87%
Profit Margin
17.11%17.54%14.36%11.47%15.95%4.47%
Free Cash Flow Margin
18.74%16.15%5.63%-8.06%7.28%0.06%
EBITDA
398.53380.66320.77235.04223.65190.74
EBITDA Margin
22.25%21.80%18.05%14.43%12.48%12.17%
D&A For EBITDA
76.6676.0673.6371.7369.6767.38
EBIT
321.87304.61247.14163.31153.98123.37
EBIT Margin
17.97%17.44%13.90%10.03%8.59%7.87%
Effective Tax Rate
15.64%14.33%12.64%11.66%15.27%22.99%
Revenue as Reported
1,7911,7461,7771,6291,7921,567
Advertising Expenses
-112.79145.4577.4434.32-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.